Cipher Pharmaceuticals Inc (CPHRF)
6.90
+0.53
(+8.32%)
USD |
OTCM |
May 20, 10:17
Cipher Pharmaceuticals Total Assets (Quarterly): 92.55M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 92.55M |
| December 31, 2023 | 86.03M |
| September 30, 2023 | 90.53M |
| June 30, 2023 | 80.61M |
| March 31, 2023 | 76.96M |
| December 31, 2022 | 73.78M |
| September 30, 2022 | 57.43M |
| June 30, 2022 | 55.95M |
| March 31, 2022 | 54.00M |
| December 31, 2021 | 51.65M |
| September 30, 2021 | 46.39M |
| June 30, 2021 | 48.07M |
| March 31, 2021 | 46.31M |
| December 31, 2020 | 44.28M |
| September 30, 2020 | 46.09M |
| June 30, 2020 | 46.01M |
| March 31, 2020 | 45.55M |
| December 31, 2019 | 46.46M |
| September 30, 2019 | 45.88M |
| June 30, 2019 | 52.96M |
| March 31, 2019 | 54.10M |
| December 31, 2018 | 55.69M |
| September 30, 2018 | 54.62M |
| June 30, 2018 | 61.00M |
| March 31, 2018 | 50.31M |
| Date | Value |
|---|---|
| December 31, 2017 | 63.01M |
| September 30, 2017 | 56.50M |
| June 30, 2017 | 54.61M |
| March 31, 2017 | 78.28M |
| December 31, 2016 | 77.23M |
| September 30, 2016 | 86.45M |
| June 30, 2016 | 109.81M |
| March 31, 2016 | 109.67M |
| December 31, 2015 | 109.65M |
| September 30, 2015 | 103.03M |
| June 30, 2015 | 106.23M |
| March 31, 2015 | 63.95M |
| December 31, 2014 | 66.06M |
| September 30, 2014 | 62.45M |
| June 30, 2014 | 56.48M |
| March 31, 2014 | 50.81M |
| December 31, 2013 | 52.17M |
| September 30, 2013 | 30.68M |
| June 30, 2013 | 26.98M |
| March 31, 2013 | 24.02M |
| December 31, 2012 | 22.07M |
| September 30, 2012 | 21.26M |
| June 30, 2012 | 19.65M |
| March 31, 2012 | 15.01M |
| December 31, 2011 | 14.36M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.28M
Minimum
Dec 2020
92.55M
Maximum
Mar 2024
59.37M
Average
52.30M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.958M |
| Shareholders Equity (Quarterly) | 85.59M |
| Current Ratio | 7.964 |